Skip to content
10-K/A

Annual Report

EIGER BIOPHARMACEUTICALS, INC.

0001193125-24-122498

← back to feed
Filed
Apr 29, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 24, 2024 1.48M sh